Transcatheter Embolization and Occlusion Devices Market Size, Share, Growth Analysis, By Type(Embolization Coils, Liquid Embolics, Embolization Particles, Flow Diverters and Occlusion Devices.), By Application(Neurology, Oncology, Cardiology, Gynecology), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2295 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 66 |Figures: 75

Transcatheter Embolization and Occlusion Devices Market Insights

Global Transcatheter Embolization and Occlusion Devices Market size was valued at USD 5.76 billion in 2021 and is poised to grow from USD 5.1 billion in 2022 to USD 13.47 billion by 2030, growing at a CAGR of 9.89% in the forecast period (2023-2030).

The global transcatheter embolization and occlusion devices market has been experiencing significant growth in recent years. Transcatheter embolization and occlusion devices are minimally invasive medical devices used to block or reduce blood flow to abnormal vessels or tissues within the body. These devices are widely used in the treatment of various medical conditions, including tumours, aneurysms, and vascular malformations. Moreover, the increasing geriatric population worldwide is driving the demand for transcatheter embolization and occlusion devices. Elderly individuals are more prone to cardiovascular diseases and various types of cancer, necessitating the use of minimally invasive treatment options. Additionally, the rising healthcare expenditure and improving healthcare infrastructure in emerging economies are further fueling market growth.

Market Snapshot - 2023-2030

Global Market Size

USD 5.76 billion

Largest Segment

Embolization Coils

Fastest Growth

Embolization Coils

Growth Rate

9.89% CAGR

Global Transcatheter Embolization and Occlusion Devices By Country ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Transcatheter Embolization and Occlusion Devices Market Segmental Analysis

The global transcatheter embolization and occlusion devices market is segmented on the basis of type, application, and region. Based on type, the market can be segmented into embolization coils, liquid embolics, embolization particles, flow diverters, and occlusion devices. Based on application, the market is segmented into neurology, oncology, cardiology, gynaecology, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Analysis by Type

Analysis of the global transcatheter embolization and occlusion devices market reveals that the most dominant type in terms of market share is embolization coils. Embolization coils are widely used in minimally invasive procedures to treat vascular abnormalities and block blood flow to target areas. Their efficacy, versatility, and established track record have contributed to their dominance in the market.

On the other hand, the fastest-growing type in the global transcatheter embolization and occlusion devices market is flow diverters. Flow diverters are advanced devices used to redirect blood flow away from an aneurysm or abnormal vessel, promoting vessel healing and reducing the risk of rupture. The increasing adoption of flow diverters in endovascular treatments, advancements in technology, and growing awareness about their benefits have propelled their rapid growth in the market.

Analysis by Application

Oncology holds the dominant position in the global transcatheter embolization and occlusion devices market. This is primarily attributed to the increasing incidence of various types of cancer, such as liver cancer, kidney cancer, and lung cancer, among others. Transcatheter embolization and occlusion devices play a crucial role in the treatment of cancer by blocking or reducing blood flow to tumours, leading to their shrinkage or destruction. The growing adoption of minimally invasive procedures and the rising preference for targeted therapies have further propelled the demand for transcatheter embolization and occlusion devices in oncology.

On the other hand, the fastest growing application in the global transcatheter embolization and occlusion devices market is Neurology. Neurological disorders, such as arteriovenous malformations (AVMs), brain aneurysms, and intracranial vascular diseases, require specialised treatment approaches. Transcatheter embolization and occlusion devices offer a less invasive alternative to traditional surgical procedures for the treatment of these conditions. The increasing prevalence of neurovascular diseases, advancements in device technology, and the growing adoption of minimally invasive techniques have contributed to the rapid growth of transcatheter embolization and occlusion devices in neurology.

Global Transcatheter Embolization and Occlusion Devices By Type

To get detailed analysis on other segments, Request For Free Sample Report

Transcatheter Embolization and Occlusion Devices Market Regional Insights

North America has emerged as the most dominant market for transcatheter embolization and occlusion devices. This can be attributed to the well-established healthcare infrastructure, high adoption rate of advanced medical technologies, and favourable reimbursement policies in countries like the United States and Canada. The presence of key market players and ongoing research and development activities in the region further contribute to its dominance.

Asia Pacific exhibits significant potential and is experiencing rapid market growth. Factors such as a large patient pool, increasing awareness about minimally invasive procedures, and the growing healthcare expenditure in countries like China, Japan, and India are driving the demand for transcatheter embolization and occlusion devices in the region. Additionally, the rise in government initiatives to improve healthcare infrastructure and the increasing focus on expanding access to quality healthcare services are fueling market growth in Asia Pacific.

Global Transcatheter Embolization and Occlusion Devices By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Transcatheter Embolization and Occlusion Devices Market Dynamics

Drivers

Growing Minimally Invasive Procedures

  • The global market for transcatheter embolization and occlusion devices is witnessing growth due to the rising demand for minimally invasive treatment options. Patients and medical professionals are increasingly opting for these procedures because they offer benefits such as faster recovery times, shorter hospital stays, and reduced risk of complications. The preference for minimally invasive procedures is a major driver behind the increasing demand for transcatheter embolization and occlusion devices.

Restraints

Risk of Complications and Adverse Events

  • While transcatheter embolization and occlusion devices are generally considered safe and effective, there is a potential for complications and adverse events during these procedures. Device-related issues like migration, vessel perforation, or thrombosis can occur, raising concerns among healthcare providers and patients. These considerations of potential risks may impact the growth of the market for transcatheter embolization and occlusion devices.

Request Free Customization of this report to help us to meet your business objectives.

Transcatheter Embolization and Occlusion Devices Market Competitive Landscape

The global transcatheter embolization and occlusion devices market is highly competitive and characterised by the presence of several major players. These companies are engaged in continuous research and development activities to introduce innovative products and gain a competitive edge in the market. The competitive landscape is shaped by factors such as product offerings, technological advancements, strategic collaborations, and geographical presence.

Top Player’s Company Profiles

  • Stryker Corporation (United States)
  • Terumo Corporation (Japan)
  • Johnson & Johnson (United States)
  • Abbott Laboratories (United States)
  • Merit Medical Systems, Inc. (United States)
  • Penumbra, Inc. (United States)
  • BTG International Ltd. (United Kingdom)
  • Cardiva Medical, Inc. (United States)
  • Cook Group Incorporated (United States)
  • Balt International (France)
  • Edwards Lifesciences Corporation (United States)
  • Penumbra, Inc. (United States)
  • Sirtex Medical Limited (Australia)
  • Teleflex Incorporated (United States)
  • Acandis GmbH (Germany)
  • AngioDynamics, Inc. (United States)
  • Gore Medical (United States)

Recent Developments

  • In July 2022, Edwards Lifesciences Corporation announced the FDA approval of its Amplatzer™ Vascular Plug II for the treatment of patients with pulmonary arteriovenous malformations (PAVMs).
  • In June 2022, Cook Medical announced the FDA approval of its NirMesh™ Vascular Occlusion Device for the treatment of patients with varicose veins.
  • In May 2022, Johnson & Johnson Services, Inc. announced the FDA approval of its Embozene™ Microspheres for the treatment of patients with symptomatic cerebral arteriovenous malformations (AVMs).
  • In April 2022, Penumbra, Inc. announced the European launch of its Penumbra® MAX System for the treatment of intracranial aneurysms.
  • In March 2022, Boston Scientific Corporation announced the FDA approval of its Solitaire™ Flow Restoration Device for the treatment of patients with symptomatic intracranial arteriovenous malformations (AVMs).

Transcatheter Embolization and Occlusion Devices Key Market Trends

  • Adoption of New Technologies: New technologies are being developed that offer improved safety and efficacy, and these new technologies are expected to drive market growth in the coming years. In addition to the increasing adoption of new technologies, other key market trends for transcatheter embolization and occlusion devices include the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the increasing adoption of reimbursement policies for these devices. As the market continues to grow, we can expect to see more innovation in the transcatheter embolization and occlusion devices industry, and this innovation is expected to help these devices become even more effective in treating a variety of medical conditions.

Transcatheter Embolization and Occlusion Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to the global transcatheter embolization and occlusion devices analysis, the increasing adoption of minimally invasive procedures as the primary drivers of the transcatheter embolization and occlusion devices market. With a rising global burden of conditions such as aneurysms, arteriovenous malformations, and uterine fibroids, there is a growing demand for effective treatment options. Transcatheter embolization and occlusion devices offer a less invasive alternative to surgical procedures, leading to reduced hospital stays, faster recovery, and improved patient outcomes.

The report emphasises the technological advancements in the field of embolization and occlusion devices. The development of advanced materials, imaging technologies, and innovative delivery systems has enabled healthcare providers to perform complex procedures with greater precision and efficacy. The introduction of next-generation devices, such as detachable coils, liquid embolics, and flow diverters, has expanded the treatment options available to physicians and enhanced patient care.

Report Metric Details
Market size value in 2021 USD 5.76 billion
Market size value in 2030 USD 13.47 billion
Growth Rate 9.89%
Base year 2023
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Embolization Coils, Liquid Embolics, Embolization Particles, Flow Diverters and Occlusion Devices.
  • Application
    • Neurology, Oncology, Cardiology, Gynecology, and Others.
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Stryker Corporation (United States)
  • Terumo Corporation (Japan)
  • Johnson & Johnson (United States)
  • Abbott Laboratories (United States)
  • Merit Medical Systems, Inc. (United States)
  • Penumbra, Inc. (United States)
  • BTG International Ltd. (United Kingdom)
  • Cardiva Medical, Inc. (United States)
  • Cook Group Incorporated (United States)
  • Balt International (France)
  • Edwards Lifesciences Corporation (United States)
  • Penumbra, Inc. (United States)
  • Sirtex Medical Limited (Australia)
  • Teleflex Incorporated (United States)
  • Acandis GmbH (Germany)
  • AngioDynamics, Inc. (United States)
  • Gore Medical (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Transcatheter Embolization and Occlusion Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Transcatheter Embolization and Occlusion Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Transcatheter Embolization and Occlusion Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Transcatheter Embolization and Occlusion Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Transcatheter Embolization and Occlusion Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Transcatheter Embolization and Occlusion Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Transcatheter Embolization and Occlusion Devices Market size was valued at USD 5.76 billion in 2021 and is poised to grow from USD 5.1 billion in 2022 to USD 13.47 billion by 2030, growing at a CAGR of 9.89% in the forecast period (2023-2030).

The global transcatheter embolization and occlusion devices market is highly competitive and characterised by the presence of several major players. These companies are engaged in continuous research and development activities to introduce innovative products and gain a competitive edge in the market. The competitive landscape is shaped by factors such as product offerings, technological advancements, strategic collaborations, and geographical presence. 'Medtronic (Ireland)', 'Boston Scientific Corporation (United States)', 'Stryker Corporation (United States)', 'Terumo Corporation (Japan)', 'Johnson & Johnson (United States)', 'Cook Medical (United States)', 'Abbott Laboratories (United States)', 'Merit Medical Systems, Inc. (United States)', 'Penumbra, Inc. (United States)', 'BTG International Ltd. (United Kingdom)', 'Cardiva Medical, Inc. (United States)', 'Cook Group Incorporated (United States)', 'Balt International (France)', 'Edwards Lifesciences Corporation (United States)', 'Penumbra, Inc. (United States)', 'Sirtex Medical Limited (Australia)', 'Teleflex Incorporated (United States)', 'Acandis GmbH (Germany)', 'AngioDynamics, Inc. (United States)', 'Gore Medical (United States)'

The global market for transcatheter embolization and occlusion devices is witnessing growth due to the rising demand for minimally invasive treatment options. Patients and medical professionals are increasingly opting for these procedures because they offer benefits such as faster recovery times, shorter hospital stays, and reduced risk of complications. The preference for minimally invasive procedures is a major driver behind the increasing demand for transcatheter embolization and occlusion devices.

Adoption of New Technologies: New technologies are being developed that offer improved safety and efficacy, and these new technologies are expected to drive market growth in the coming years. In addition to the increasing adoption of new technologies, other key market trends for transcatheter embolization and occlusion devices include the increasing prevalence of chronic diseases, the rising demand for minimally invasive procedures, and the increasing adoption of reimbursement policies for these devices. As the market continues to grow, we can expect to see more innovation in the transcatheter embolization and occlusion devices industry, and this innovation is expected to help these devices become even more effective in treating a variety of medical conditions.

North America has emerged as the most dominant market for transcatheter embolization and occlusion devices. This can be attributed to the well-established healthcare infrastructure, high adoption rate of advanced medical technologies, and favourable reimbursement policies in countries like the United States and Canada. The presence of key market players and ongoing research and development activities in the region further contribute to its dominance.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35A2295

$5,300
BUY NOW GET FREE SAMPLE